Medicare Enrolled

Dr. Edna Scheindling-Tokayer, MD

Endocrinology · Boca Raton, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
2900 N MILITARY TRAIL, Boca Raton, FL 33431
5612355980
In practice since 2006 (19 years)
NPI: 1184638710 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Scheindling-Tokayer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Scheindling-Tokayer? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Scheindling-Tokayer

Dr. Edna Scheindling-Tokayer is an endocrinology in Boca Raton, FL, with 19 years in practice. Based on federal Medicare data, Dr. Scheindling-Tokayer performed 5,954 Medicare services across 1,760 unique beneficiaries.

Between the years covered by Open Payments, Dr. Scheindling-Tokayer received a total of $21,018 from 70 pharmaceutical and/or device companies across 1176 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Scheindling-Tokayer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 10% volume in FL$ $21,018 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,954
Medicare services
Top 10% in FL for endocrinology
1,760
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~313 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)3,290$19$40
Office visit, established patient (30-39 min)1,253$100$225
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report318$27$80
Ultrasound scan of head and neck soft tissue262$86$243
Blood glucose (sugar) test performed by hand-held instrument232$3$10
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment145$113$320
Office visit, established patient, complex (40-54 min)106$143$302
New patient office visit (45-59 min)99$132$345
Telephone medical discussion with physician, 11-20 minutes61$73$150
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle56$57$168
New patient office visit, complex (60-74 min)45$177$435
Office visit, established patient (20-29 min)37$71$152
Fine needle aspiration biopsy using ultrasound guidance, first growth20$103$270
Telephone medical discussion with physician, 21-30 minutes17$103$200
Telephone medical discussion with physician, 5-10 minutes13$45$90
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$21,018
Total received (2018-2024)
Avg $3,003/year across 7 years
Top 18% in FL for endocrinology
70
Companies
1,176
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,018 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,454
2023
$2,882
2022
$3,472
2021
$3,059
2020
$2,536
2019
$3,064
2018
$2,552

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$2,804
Lilly USA, LLC
$2,548
SANOFI-AVENTIS U.S. LLC
$2,072
AstraZeneca Pharmaceuticals LP
$1,359
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,143
Xeris Pharmaceuticals, Inc.
$983
Amgen Inc.
$761
Corcept Therapeutics
$705
Insulet Corporation
$618
Merck Sharp & Dohme Corporation
$570
Abbott Laboratories
$523
Mannkind Corporation
$516
Radius Health, Inc.
$509
MannKind Corporation
$406
Dexcom, Inc.
$360
Amneal Pharmaceuticals LLC
$306
Bayer Healthcare Pharmaceuticals Inc.
$282
AbbVie, Inc.
$257
Bayer HealthCare Pharmaceuticals Inc.
$257
Horizon Therapeutics plc
$255
AbbVie Inc.
$231
IBSA Pharma Inc.
$192
Zealand Pharma US, Inc.
$182
Antares Pharma, Inc.
$178
Senseonics, Incorporated
$176
Janssen Pharmaceuticals, Inc
$176
Novartis Pharmaceuticals Corporation
$165
Valeritas, Inc.
$154
ABBVIE INC.
$149
Amarin Pharma Inc.
$148
Tandem Diabetes Care, Inc.
$141
BETA BIONICS, INC.
$139
Medtronic, Inc.
$137
RECORDATI_RARE_DISEASES_INC.
$135
LIFESCAN, INC.
$94
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$86
Shire North American Group Inc
$77
VIVUS LLC
$76
Becton, Dickinson and Company
$71
Embecta Corp.
$69
Alexion Pharmaceuticals, Inc.
$65
DEXCOM, INC.
$63
VIVUS, Inc.
$62
Currax Pharmaceuticals LLC
$59
Nevro Corp.
$53
Amphastar Pharmaceuticals, Inc.
$49
Kyowa Kirin, Inc.
$47
Ultragenyx Pharmaceutical Inc.
$45
PFIZER INC.
$45
Supernus Pharmaceuticals, Inc.
$42
EUSA Pharma (US) LLC
$40
Ascensia Diabetes Care US Inc.
$37
Gemini Laboratories, LLC
$36
Endo Pharmaceuticals Inc.
$34
Acella Pharmaceuticals, LLC
$33
Madrigal Pharmaceuticals
$29
Medtronic MiniMed, Inc.
$28
CeQur Corporation
$26
Ascendis Pharma Inc
$25
Esperion Therapeutics, Inc.
$23
Azurity Pharmaceuticals, Inc.
$21
Astellas Pharma US Inc
$20
Amryt Pharma Holdings Ltd
$18
Strongbridge US INC.
$18
Alfasigma USA, Inc.
$18
RGH Enterprises LLC
$17
LifeScan, Inc.
$17
Tolmar, Inc.
$13
Intuity Medical Inc
$12
Roche Diabetes Care, Inc.
$12
Top 3 companies account for 35.3% of total payments
Associated products mentioned in payments ›
AFREZZA · AVEED · Adthyza · Androgel · BAQSIMI · BASAGLAR · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · CONTRAVE · CRYSVITA · CYCLOSET · Cables · CeQur Simplicity · Crysvita · DC ACCU-CHEK Diabetes Management Solutions · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · Eversense · FARXIGA · FIASP · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN R 500 · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Kits and Accessories · Korlym · LEQVIO · LICART · LOKELMA · MACRILEN · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NP Thyroid · NP Thyroid 60 · ONETOUCH VERIO REFLECT · Omnipod · One Touch Reveal Mobile App · Ozempic · Pogo Automatic Blood Glucose Monitoring System · Prolia · QSYMIA · Qsymia · RECORLEV · RESMETIROM · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLUJAN · STRENSIQ · SYNTHROID · Saxenda · Senza · Software · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · V-GO · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $353 per 100 Medicare services performed
Looking for a endocrinology in Boca Raton?
Compare endocrinologys in the Boca Raton area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
74
Per 100K population
4.9
County median income
$81,115
Nearest hospital
BOCA RATON REGIONAL HOSPITAL
1.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Scheindling-Tokayer is a clinical cardiology specialist, with above-average Medicare volume (top 10% in FL), and high industry engagement (low-engagement, top 18%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Scheindling-Tokayer experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Scheindling-Tokayer performed 3,290 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Scheindling-Tokayer receive payments from pharmaceutical companies?
Yes. Dr. Scheindling-Tokayer received a total of $21,018 from 70 companies across 1,176 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Scheindling-Tokayer's costs compare to other endocrinologys in Boca Raton?
Dr. Scheindling-Tokayer's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Scheindling-Tokayer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →